 Combined hepatitis A and B vaccine (Twinrix) | |
| Combination of | |
|---|---|
| Hepatitis A vaccine | Vaccine |
| Hepatitis B vaccine | Vaccine |
| Clinical data | |
| Trade names | Twinrix, Ambirix, others |
| AHFS/Drugs.com | FDA Professional Drug Information |
| License data | |
| Pregnancy category |
|
| Routes of administration | Intramuscular |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
Combinedhepatitis A andB vaccine, is used to provide protection againsthepatitis A andhepatitis B.[3][7] It is given by injectioninto muscle.[8]
It is used in areas where hepatitis A and B are endemic, for travelers, people withhepatitis C or chronic liver disease, and those at high risk ofsexually transmitted diseases.[7]
The combined vaccine is as safe and protective as if given as separate hepatitis A and B vaccines.[7] It is generally well-tolerated.[9] Common side effects are mild and include redness and pain at the injection site, where a small lump may appear.[8] Feeling faint or tired, or a headache may occur.[8] Other side effects include numbness, tingling, rash, bruising, abnormal bleeding such as from the nose or gums, weak muscle or pain.[8] Severe side effects are rare and include an allergic reaction and seizures.[8]
It is widely available.[7]
Routine Twinrix vaccination is administered by intramuscular injection in thedeltoid area using a schedule of three separate doses at 0, 1, and 6 months ([minimum intervals: 4 weeks between doses 1 and 2, 5 months between doses 2 and 3]).[3][10] In some circumstances, an accelerated dosing schedule of 0, 7 and 21 to 30 days followed by a booster at 12 months can be used and was shown to have similar efficacy as the traditional schedule.[11]
The U.S.Centers for Disease Control and Prevention (CDC) reports that clinical trials found the following levels of protection against Hepatitis A and Hepatitis B one month after each dose:[12]
Twinrix is a brand manufactured byGlaxoSmithKline Biologicals. The full generic name ishepatitis Ainactivated &hepatitis B (recombinant) vaccine.[13] Twinrix is administered over three doses. The name was created because it is a mixture of two earlier vaccines —Havrix, aninactivated-virusHepatitis A vaccine, andEngerix-B, arecombinantHepatitis B vaccine.[citation needed] Twinrix first entered the market in early 1997.[14]
In the United States, Twinrix is approved by theFood and Drug Administration (FDA) for those aged 18 and older.[3][12] In some countries outside the United States, notably Canada and in the European Union, Twinrix is known as Twinrix Adult or Ambirix and a pediatric formulation, called Twinrix Junior or Twinrix Paediatric, is available.[15][16][17][18][19][20][21][22][excessive citations]
By being a combination it may reduce administrative costs and achieve a better uptake of the vaccine.[23]
Brand names include Twinrix, Twinrix Junior, Twinrix paediatric, Ambirix,[7] and Bilive.[9]
This article incorporates text from this source, which is in thepublic domain.| Subsidiaries |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Predecessors, acquisitions | |||||||||
| Products |
| ||||||||
| People |
| ||||||||
| Litigation | |||||||||
| Other | |||||||||
